Alzamend Neuro Inc.
09/25/2025 | Press release | Distributed by Public on 09/25/2025 14:31
Private Placement (Form 8-K)
| Item 3.02 | Unregistered Sales of Equity Securities. |
Between September 17, 2025 and September 25, 2025, Alzamend Neuro, Inc. (the "Company") issued an aggregate of 300,000 shares of common stock, par value $0.0001 per share ("Common Stock") upon conversion of an aggregate of 696 shares of Series B Convertible Preferred Stock. The shares of Common Stock were issued in reliance upon exemption from the registration requirements under Section 4(a)(2) under the Securities Act.
As of September 25, 2025, the Company had 3,439,861 shares of Common Stock outstanding.
Alzamend Neuro Inc. published this content on September 25, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 25, 2025 at 20:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]